5-162149152-C-T

Variant summary

Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_198904.4(GABRG2):​c.967C>T​(p.Arg323Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R323Q) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

GABRG2
NM_198904.4 missense

Scores

14
4
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 3.38
Variant links:
Genes affected
GABRG2 (HGNC:4087): (gamma-aminobutyric acid type A receptor subunit gamma2) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammlian brain, where it acts at GABA-A receptors, which are ligand-gated chloride channels. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene have been associated with epilepsy and febrile seizures. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 17 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr5-162149153-G-A is described in Lovd as [Pathogenic].
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), GABRG2. . Gene score misZ 2.9939 (greater than the threshold 3.09). Trascript score misZ 3.9213 (greater than threshold 3.09). GenCC has associacion of gene with epilepsy, Dravet syndrome, undetermined early-onset epileptic encephalopathy, generalized epilepsy with febrile seizures plus, developmental and epileptic encephalopathy, 74, febrile seizures, familial, 8, childhood epilepsy with centrotemporal spikes.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.957
PP5
Variant 5-162149152-C-T is Pathogenic according to our data. Variant chr5-162149152-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 205549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GABRG2NM_198904.4 linkuse as main transcriptc.967C>T p.Arg323Trp missense_variant 8/10 ENST00000639213.2 NP_944494.1 P18507-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GABRG2ENST00000639213.2 linkuse as main transcriptc.967C>T p.Arg323Trp missense_variant 8/101 NM_198904.4 ENSP00000491909.2 P18507-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1461780
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
727198
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000111
Hom.:
0

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Febrile seizures, familial, 8 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterNov 10, 2023Criteria applied: PS2_VSTR,PS4_MOD,PM1,PM5,PS3_SUP,PM2,PP3 -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxJun 03, 2022Published functional studies demonstrate a damaging effect; specifically, expression of R323W in HEK293 cells led to significantly reduced GABA-evoked currents, increased zinc sensitivity and reduced surface expression, and altered receptor kinetics by accelerating channel deactivation (Shen et al., 2017); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28684954, 27864268, 30190672, 31087664, 29933521, 35359574) -
Intellectual disability Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingDiagnostic Laboratory, Strasbourg University HospitalSep 10, 2020- -
Febrile seizures, familial, 8;C5193074:Developmental and epileptic encephalopathy, 74 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital BonnDec 06, 2023- -
Epilepsy, childhood absence 2;C1969810:Febrile seizures, familial, 8 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 09, 2023This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 323 of the GABRG2 protein (p.Arg323Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with early-onset epilepsy (PMID: 27864268; Invitae). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 205549). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GABRG2 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GABRG2 function (PMID: 27864268). This variant disrupts the p.Arg323 amino acid residue in GABRG2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23708187). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.36
D
BayesDel_noAF
Pathogenic
0.28
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.93
.;.;.;.;.;.;D;.;.;.;.;.;.;.
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.55
D
MetaRNN
Pathogenic
0.96
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.58
D
MutationAssessor
Pathogenic
3.6
.;.;.;.;H;.;H;.;.;.;.;.;.;.
PrimateAI
Pathogenic
0.91
D
PROVEAN
Pathogenic
-7.4
.;.;.;.;.;.;.;.;.;.;.;D;D;.
REVEL
Pathogenic
0.82
Sift
Pathogenic
0.0
.;.;.;.;.;.;.;.;.;.;.;D;D;.
Sift4G
Pathogenic
0.0
.;.;.;.;.;.;.;.;.;.;.;D;.;.
Polyphen
1.0
.;.;.;.;D;.;D;.;.;.;.;.;.;.
Vest4
0.90
MutPred
0.85
.;.;.;.;Loss of disorder (P = 0.0137);.;Loss of disorder (P = 0.0137);.;Loss of disorder (P = 0.0137);.;Loss of disorder (P = 0.0137);.;.;Loss of disorder (P = 0.0137);
MVP
0.92
MPC
2.6
ClinPred
1.0
D
GERP RS
2.0
Varity_R
0.90
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs796052510; hg19: chr5-161576158; API